8 min listen
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
ratings:
Length:
8 minutes
Released:
Aug 30, 2023
Format:
Podcast episode
Description
In this episode, we delve into a new horizon in the management of acute agitation. We discuss dexmedetomidine, a drug that's been around since 1999, recently reformulated into a sublingual film and FDA approved for treating agitation associated with schizophrenia or bipolar I or II disorder. We explore the results from a recent randomized trial and its potential for transforming psychiatric care. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 47 Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial
Released:
Aug 30, 2023
Format:
Podcast episode
Titles in the series (100)
Antidepressants and Vertebral and Hip Risk Fractures: In this episode, we discuss an updated review of 11 studies that seek to evaluate the effect of antidepressants on the risk of hip and vertebral bone fractures. Although the overall effect size seems large, the absolute risk increase might be small.... by Psychopharmacology and Psychiatry Updates